Friday morning snapshot

A snapshot of the early morning's equity news and key market movements.

Last night in the US: The Dow Jones closed down 21 points at 16,558, the NASDAQ finished up 12 points at 3594 and the S&P 500 ended the day down one point at 1883.

This morning in London: The FTSE 100 is currently down eight points at 6801.

FX and commodities: GBP/USD is down three pips at $1.6892, EUR/USD is down 16 pips at $1.3853 and USD/JPY is up 16 pips at ¥102.49. Brent crude is up 25 cents at $108.08 and gold is trading at $1283, down $1.

Stocks: Royal Bank of Scotland posted a 99% increase in its first-quarter pre-tax profits. Pfizer increased its offer for AstraZeneca to £50 per share; the previous offer was £46.61 per share.

The day ahead: The eurozone manufacturing purchasing managers index is out at 9am, followed by UK construction PMI at 9.30am, and eurozone unemployment data.

In the US, non-farm payrolls and unemployment data will be released at 1.30pm, followed by factory orders at 3pm.

All figures correct at 8.15am. All times London time.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.